目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths and weaknesses of leading players?
7.4. How have leading players responded to the COVID-19 pandemic?
7.5. Are there any threats toward leading players?

8 Company Profiles
8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. Johnson & Johnson
8.4. Pfizer Inc.

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Europe pharmaceuticals market value: $ billion, 2016-21
Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Europe pharmaceuticals market value forecast: $ billion, 2021-26
Table 4: Europe pharmaceuticals market share: % share, by value, 2021
Table 5: F. Hoffmann-La Roche Ltd: key facts
Table 6: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 7: F. Hoffmann-La Roche Ltd: Key Employees
Table 8: Novartis AG: key facts
Table 9: Novartis AG: Annual Financial Ratios
Table 10: Novartis AG: Key Employees
Table 11: Novartis AG: Key Employees Continued
Table 12: Johnson & Johnson: key facts
Table 13: Johnson & Johnson: Annual Financial Ratios
Table 14: Johnson & Johnson: Key Employees
Table 15: Johnson & Johnson: Key Employees Continued
Table 16: Pfizer Inc.: key facts
Table 17: Pfizer Inc.: Annual Financial Ratios
Table 18: Pfizer Inc.: Key Employees
Table 19: Pfizer Inc.: Key Employees Continued
Table 20: Europe size of population (million), 2017-21
Table 21: Europe gdp (constant 2005 prices, $ billion), 2017-21
Table 22: Europe gdp (current prices, $ billion), 2017-21
Table 23: Europe inflation, 2017-21
Table 24: Europe consumer price index (absolute), 2017-21
Table 25: Europe exchange rate, 2017-21

List of Figures
Figure 1: Europe pharmaceuticals market value: $ billion, 2016-21
Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Europe pharmaceuticals market value forecast: $ billion, 2021-26
Figure 4: Forces driving competition in the pharmaceuticals market in Europe, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Europe, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Europe, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2021
Figure 10: Europe pharmaceuticals market share: % share, by value, 2021